News & Investors

Convertible bonds 2021/2024

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.


This website and the information contained therein do not constitute an offer to sell or a solicitation of an offer to buy any securities of Epigenomics AG in the United States of America (“U.S.”) or in any other jurisdiction or to any person if such offer or solicitation is unlawful or not authorized. Users of this website are requested to inform themselves about and to observe any such restrictions. The information set forth on this website must not be distributed in or to the U.S., to “U.S. persons” as defined in Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or to publications with a general circulation in the U.S. Each violation of such limitations may constitute a violation of applicable securities laws.

The securities of Epigenomics AG described herein (the “securities”) have not been and will not be registered under the Securities Act and may not be offered or sold in the U.S. unless pursuant to an exemption from registration requirements. There will be no public offering of the securities in the U.S.

By clicking on the “I agree” button below, you warrant that (a) you are located in, or a resident of, Germany, and (b) if you are located, or your residency is, outside Germany, you are (i) no “U.S. person” within the meaning of the Securities Act and (ii) you are located outside the U.S., Canada, Australia or Japan or any other jurisdictions in which the distribution or release would be unlawful and (c) if you are located in, or a resident of, the U.S., you are a qualified institutional buyer within the meaning of the Securities Act.

I agree

I do not agree